An interesting possibility for future research would be to expand the DSC2 analyses to circulating tumour cells and clusters, as well as pulmonary breast cancer metastases, in order to further clarify the potential of DSC2 as a breast cancer brain and pulmonary metastases marker for clinical use. Here, DSC2 is linked to breast carcinoma.